Immunovantinc Stock Market Value
| IMVT Stock | USD 28.80 0.19 0.66% |
| Symbol | ImmunovantInc |
ImmunovantInc Price To Book Ratio
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
ImmunovantInc 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ImmunovantInc's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ImmunovantInc.
| 03/26/2024 |
| 04/25/2024 |
If you would invest 0.00 in ImmunovantInc on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding ImmunovantInc or generate 0.0% return on investment in ImmunovantInc over 30 days. ImmunovantInc is related to or competes with Arbutus Biopharma, Arcutis BiotherapeuticsI, Legend BiotechCorp, Protagonist Therapeutics, Akero Therapeutics, Madrigal Pharmaceuticals, and Apellis Pharmaceuticals. Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoim... More
ImmunovantInc Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ImmunovantInc's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ImmunovantInc upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 11.29 | |||
| Value At Risk | (4.46) | |||
| Potential Upside | 3.47 |
ImmunovantInc Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ImmunovantInc's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ImmunovantInc's standard deviation. In reality, there are many statistical measures that can use ImmunovantInc historical prices to predict the future ImmunovantInc's volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.57) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.59) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of ImmunovantInc's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
ImmunovantInc Backtested Returns
ImmunovantInc holds Efficiency (Sharpe) Ratio of -0.17, which attests that the entity had a -0.17% return per unit of risk over the last 3 months. ImmunovantInc exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out ImmunovantInc's Market Risk Adjusted Performance of (0.58), risk adjusted performance of (0.12), and Standard Deviation of 2.42 to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.84, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, ImmunovantInc's returns are expected to increase less than the market. However, during the bear market, the loss of holding ImmunovantInc is expected to be smaller as well. ImmunovantInc has an expected return of -0.43%. Please make sure to check out ImmunovantInc jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if ImmunovantInc performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.43 |
Average predictability
ImmunovantInc has average predictability. Overlapping area represents the amount of predictability between ImmunovantInc time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ImmunovantInc price movement. The serial correlation of 0.43 indicates that just about 43.0% of current ImmunovantInc price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.43 | |
| Spearman Rank Test | 0.78 | |
| Residual Average | 0.0 | |
| Price Variance | 1.0 |
ImmunovantInc lagged returns against current returns
Autocorrelation, which is ImmunovantInc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting ImmunovantInc's stock expected returns. We can calculate the autocorrelation of ImmunovantInc returns to help us make a trade decision. For example, suppose you find that ImmunovantInc has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
ImmunovantInc regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If ImmunovantInc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if ImmunovantInc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in ImmunovantInc stock over time.
Current vs Lagged Prices |
| Timeline |
ImmunovantInc Lagged Returns
When evaluating ImmunovantInc's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of ImmunovantInc stock have on its future price. ImmunovantInc autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, ImmunovantInc autocorrelation shows the relationship between ImmunovantInc stock current value and its past values and can show if there is a momentum factor associated with investing in ImmunovantInc.
Regressed Prices |
| Timeline |
ImmunovantInc Investors Sentiment
The influence of ImmunovantInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ImmunovantInc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ImmunovantInc's public news can be used to forecast risks associated with an investment in ImmunovantInc. The trend in average sentiment can be used to explain how an investor holding ImmunovantInc can time the market purely based on public headlines and social activities around ImmunovantInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ImmunovantInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ImmunovantInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ImmunovantInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ImmunovantInc.
ImmunovantInc Implied Volatility | 78.88 |
ImmunovantInc's implied volatility exposes the market's sentiment of ImmunovantInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ImmunovantInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ImmunovantInc stock will not fluctuate a lot when ImmunovantInc's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunovantInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunovantInc's short interest history, or implied volatility extrapolated from ImmunovantInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ImmunovantInc Correlation, ImmunovantInc Volatility and ImmunovantInc Alpha and Beta module to complement your research on ImmunovantInc. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ImmunovantInc Stock analysis
When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |
ImmunovantInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.